Please login to the form below

Not currently logged in
Email:
Password:

ZP2929

This page shows the latest ZP2929 news and features for those working in and with pharma, biotech and healthcare.

Boehringer switches diabetes candidate in Zealand collaboration

Boehringer switches diabetes candidate in Zealand collaboration

Will swap ZP2929 for another GLP-1 receptor agonist. Boehringer Ingelheim has decided to drop the diabetes and obesity drug candidate ZP2929 it has spent nearly three years developing with Zealand ... No specific reason was given for Boehringer's

Latest news

  • Drug delivery

    Other deals of note were Boehringer Ingelheim's (BI) agreement with Zealand Pharma for rights to its ZP2929 - GLP1 receptor agonists against type 2 diabetes and obesity, further building the ... DPP-IV inhibitors (T2D) patent estate. Divestment. 609.

  • Boehringer and Zealand focus on diabetes

    Boehringer Ingelheim will obtain global development and commercialisation rights to ZP2929, Zealand Pharma's lead glucagon/GLP-1 dual agonist drug candidate. ... Zealand Pharma will be eligible to receive payments for ZP2929 and could receive additional

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics